Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
National Institutes of Health
Grant from National Institutes of Health. Official source review is required before action.
- Benefit
- $150,000
- Deadline
- Aug 11, 2027
- Audience
- State governments, Public housing authorities/Indian housing authorities
- Objective OIP Score
- 72/100